177 related articles for article (PubMed ID: 29467412)
1. IL-32 gamma reduces lung tumor development through upregulation of TIMP-3 overexpression and hypomethylation.
Yun J; Park MH; Son DJ; Nam KT; Moon DB; Ju JH; Hwang OK; Choi JS; Kim TH; Jung YS; Hwang DY; Han SB; Yoon DY; Hong JT
Cell Death Dis; 2018 Feb; 9(3):306. PubMed ID: 29467412
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of skin carcinogenesis by suppression of NF-κB dependent ITGAV and TIMP-1 expression in IL-32γ overexpressed condition.
Lee YS; Lee CH; Bae JT; Nam KT; Moon DB; Hwang OK; Choi JS; Kim TH; Jun HO; Jung YS; Hwang DY; Han SB; Yoon DY; Hong JT
J Exp Clin Cancer Res; 2018 Nov; 37(1):293. PubMed ID: 30486830
[TBL] [Abstract][Full Text] [Related]
3. Loss of TIMP-3 promotes tumor invasion via elevated IL-6 production and predicts poor survival and relapse in HPV-infected non-small cell lung cancer.
Wu DW; Tsai LH; Chen PM; Lee MC; Wang L; Chen CY; Cheng YW; Lee H
Am J Pathol; 2012 Nov; 181(5):1796-806. PubMed ID: 22982189
[TBL] [Abstract][Full Text] [Related]
4. IL-32γ inhibits cancer cell growth through inactivation of NF-κB and STAT3 signals.
Oh JH; Cho MC; Kim JH; Lee SY; Kim HJ; Park ES; Ban JO; Kang JW; Lee DH; Shim JH; Han SB; Moon DC; Park YH; Yu DY; Kim JM; Kim SH; Yoon DY; Hong JT
Oncogene; 2011 Jul; 30(30):3345-59. PubMed ID: 21423208
[TBL] [Abstract][Full Text] [Related]
5. IL-32γ suppresses lung cancer stem cell growth via inhibition of ITGAV-mediated STAT5 pathway.
Lee YS; Kim KC; Mongre RK; Kim JY; Kim YR; Choi DY; Song S; Yun J; Han SB; Yoon DY; Hong JT
Cell Death Dis; 2019 Jul; 10(7):506. PubMed ID: 31263095
[TBL] [Abstract][Full Text] [Related]
6. Expression and inhibitory role of TIMP-3 in hepatocellular carcinoma.
Shen B; Jiang Y; Chen YR; Zheng HC; Zeng W; Li YY; Yin A; Nie Y
Oncol Rep; 2016 Jul; 36(1):494-502. PubMed ID: 27222429
[TBL] [Abstract][Full Text] [Related]
7. Tissue inhibitor of matrix metalloproteinase-3 has both anti-metastatic and anti-tumourigenic properties.
Rai GP; Baird SK
Clin Exp Metastasis; 2020 Feb; 37(1):69-76. PubMed ID: 31894441
[TBL] [Abstract][Full Text] [Related]
8. IL-32γ suppressed atopic dermatitis through inhibition of miR-205 expression via inactivation of nuclear factor-kappa B.
Lee YS; Han SB; Ham HJ; Park JH; Lee JS; Hwang DY; Jung YS; Yoon DY; Hong JT
J Allergy Clin Immunol; 2020 Jul; 146(1):156-168. PubMed ID: 31931018
[TBL] [Abstract][Full Text] [Related]
9. Cleavage and polyadenylation specific factor 4 targets NF-κB/cyclooxygenase-2 signaling to promote lung cancer growth and progression.
Yi C; Wang Y; Zhang C; Xuan Y; Zhao S; Liu T; Li W; Liao Y; Feng X; Hao J; Gao Y; Yu W; Chen Y; Zhang C; Guo W; Tang B; Deng W
Cancer Lett; 2016 Oct; 381(1):1-13. PubMed ID: 27450326
[TBL] [Abstract][Full Text] [Related]
10. Calpain-2 triggers prostate cancer metastasis via enhancing CRMP4 promoter methylation through NF-κB/DNMT1 signaling pathway.
Gao X; Mao YH; Xiao C; Li K; Liu W; Li LY; Pang J
Prostate; 2018 Jun; 78(9):682-690. PubMed ID: 29601651
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-32γ attenuates ethanol-induced liver injury by the inhibition of cytochrome P450 2E1 expression and inflammatory responses.
Lee DH; Kim DH; Hwang CJ; Song S; Han SB; Kim Y; Yoo HS; Jung YS; Kim SH; Yoon DY; Hong JT
Clin Sci (Lond); 2015 May; 128(10):695-706. PubMed ID: 25583360
[TBL] [Abstract][Full Text] [Related]
12. MyD88 hypermethylation mediated by DNMT1 is associated with LTA-induced inflammatory response in human odontoblast-like cells.
Meng R; Li D; Feng Z; Xu Q
Cell Tissue Res; 2019 Jun; 376(3):413-423. PubMed ID: 30707290
[TBL] [Abstract][Full Text] [Related]
13. IL-32gamma induces the maturation of dendritic cells with Th1- and Th17-polarizing ability through enhanced IL-12 and IL-6 production.
Jung MY; Son MH; Kim SH; Cho D; Kim TS
J Immunol; 2011 Jun; 186(12):6848-59. PubMed ID: 21551364
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of EZH2 via activation of SAPK/JNK and reduction of p65 and DNMT1 as a novel mechanism in inhibition of human lung cancer cells by polyphyllin I.
Li L; Wu J; Zheng F; Tang Q; Wu W; Hann SS
J Exp Clin Cancer Res; 2016 Jul; 35(1):112. PubMed ID: 27421653
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of FOXO3a by DNMT1 promotes breast cancer stem cell properties and tumorigenesis.
Liu H; Song Y; Qiu H; Liu Y; Luo K; Yi Y; Jiang G; Lu M; Zhang Z; Yin J; Zeng S; Chen X; Deng M; Jia X; Gu Y; Chen D; Zheng G; He Z
Cell Death Differ; 2020 Mar; 27(3):966-983. PubMed ID: 31296961
[TBL] [Abstract][Full Text] [Related]
16. Role of NADPH oxidase NOX5-S, NF-κB, and DNMT1 in acid-induced p16 hypermethylation in Barrett's cells.
Hong J; Li D; Wands J; Souza R; Cao W
Am J Physiol Cell Physiol; 2013 Nov; 305(10):C1069-79. PubMed ID: 24025864
[TBL] [Abstract][Full Text] [Related]
17. Higher levels of TIMP-1 expression are associated with a poor prognosis in triple-negative breast cancer.
Cheng G; Fan X; Hao M; Wang J; Zhou X; Sun X
Mol Cancer; 2016 Apr; 15(1):30. PubMed ID: 27130446
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 6 induces cell proliferation of clear cell renal cell carcinoma by suppressing hepaCAM via the STAT3-dependent up-regulation of DNMT1 or DNMT3b.
Quan Z; He Y; Luo C; Xia Y; Zhao Y; Liu N; Wu X
Cell Signal; 2017 Apr; 32():48-58. PubMed ID: 28093267
[TBL] [Abstract][Full Text] [Related]
19. IL-6 enriched lung cancer stem-like cell population by inhibition of cell cycle regulators via DNMT1 upregulation.
Liu CC; Lin JH; Hsu TW; Su K; Li AF; Hsu HS; Hung SC
Int J Cancer; 2015 Feb; 136(3):547-59. PubMed ID: 24947242
[TBL] [Abstract][Full Text] [Related]
20. DNMT1-maintained hypermethylation of Krüppel-like factor 5 involves in the progression of clear cell renal cell carcinoma.
Fu RJ; He W; Wang XB; Li L; Zhao HB; Liu XY; Pang Z; Chen GQ; Huang L; Zhao KW
Cell Death Dis; 2017 Jul; 8(7):e2952. PubMed ID: 28749461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
